Figure 1
From: Prognostic impact of CD133 expression in Endometrial Cancer Patients
Endometrioid adenocarcinoma of the endometrium. A1 B1 C1: HE*10. Glandular neoplastic endometrioid tumor. A2: CD133− immunostaining. endometrioid endometrial carcinoma grade 1. B2: CD133+ immunostaining <10% endometrioid endometrial carcinoma grade 1. C2: CD133+ immunostaining >10% endometrioid endometrial carcinoma grade 1.
